Approvals/NMPA/Indacaterol Acetate, Glycopyrronium Bromide and Mometasone Furoate Powder for Inhalation（Ⅱ）

Approved

化学药品

Indacaterol Acetate, Glycopyrronium Bromide and Mometasone Furoate Powder for Inhalation（Ⅱ）

GRAND MEDICAL PTY LTD.🇨🇳 National Medical Products Administration

Approval Id: 887BGYD89Oy
Approval Number: 国药准字HJ20210034
Generic Name: 茚达格莫吸入粉雾剂(Ⅱ)
Generic Name En: Indacaterol Acetate, Glycopyrronium Bromide and Mometasone Furoate Powder for Inhalation（Ⅱ）
Drug Type: 化学药品
Dosage Form: 吸入粉雾剂
Strength: 每粒含醋酸茚达特罗150μg（以C₂₄H₂₈N₂O₃计）、格隆溴铵50μg（以C₁₉H₂₈NO₃计）和糠酸莫米松160μg。
Reg Date: 2021-05-19
Expired Date: 2026-05-18
Company Name: GRAND MEDICAL PTY LTD.
Company Detail Path: /organization/grand-medical-pty-ltd

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

May 19, 2021

Approval ID

887BGYD89Oy

Type

化学药品